Myristoleic acid produced by enterococci reduces obesity through brown adipose tissue activation

Our results demonstrated that the gut microbiota-LCFA-BAT axis plays an important role in host metabolism, which may provide a strategic advantage for the next generation of anti-obesity drug development.